Novartis Investigative Site

Daejeon, Korea 35015

0 studies enrolling now · 3 studies all time

What they study most

Acute Heart Failure, Atherosclerosis, Moderate to Severe Plaque-type Psoriasis

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early